Mood and anxiety disorders are widespread, disabling illnesses that affect more than 1 in 10 people at one point in their life. These disorders represent one of the most significant public health problems worldwide.
We offer an extensive range of clinical services for adults, adolescents, and children with mood and anxiety disorders, as well as for patients with traumatic stress disorders at:
Expert clinicians specializing in psychopharmacology and a variety of psychotherapeutic approaches offer both inpatient and outpatient treatment settings. In addition, specialized neuropsychological testing and evaluation.
Groundbreaking research underway at the Mood and Anxiety Disorders Program at The Friedman Brain Institute is yielding novel insights into the causes and pathophysiology of depression, anxiety, and post-traumatic stress disorder–knowledge that is driving discoveries of fundamentally new treatments. Research is also underway into obsessive-compulsive and related disorders.
For example, Mount Sinai scientists and physicians have played a leading role in the development of Ketamine as the first rapidly acting antidepressant medication. In addition, at the Center for Neuromodulation, we are exploring the use of deep brain stimulation to treat these disorders. This research is tightly linked to efforts to understand the neurobiology of depression, anxiety, and traumatic disorders in animal models.